UNSPSC 85603816: Restriction of rectum with intraluminal device, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to restriction of rectum with intraluminal device, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0DVP4DZ

UNSPSC 85603816 Restriction of rectum with intraluminal device, percutaneous endoscopic approach (Commodity) shows little relevant recent activity in state and local procurement. The code nominally describes a clinical medical procedure, but the recent opportunities tagged under it do not reflect gastroenterological or rectal intervention services. Instead, the flagged solicitations span occupational medical surveillance, disability medical record review and independent medical evaluations, pharmacy benefit management, surgical carve-out networks, temporary health professional staffing qualification pools, and pediatric detention-facility emergency care—none of which align with the code's stated clinical scope. The mismatch suggests either miscoding on the issuing bodies' side or a fundamental disconnect between the taxonomy and actual procurement use at this code level.

The six recent opportunities originate from disparate issuing bodies: the City of Phoenix Retirement Office (Arizona), the City of Long Beach (California), the Washington State Department of Transportation, Harris County Juvenile Probation Department (Texas), Collier County Board of County Commissioners (Florida), and the County of Santa Clara Health System (California). Geographic spread spans Arizona, California, Florida, Texas, and Washington, with no concentration pattern. The largest opportunity by scope is Collier County's RFP 25-8414 for Pharmacy Benefit Management Services covering approximately 2,400 employees and 4,800 covered members with historical annual pharmacy spending around $8.7 million and a three-year initial term through December 31, 2028. Given the wide divergence between the code's clinical name and the actual work being procured, practitioners should treat this code as inactive or miscoded for state and local purposes and verify scope alignment with issuing bodies directly rather than relying on the taxonomy designation.